Loading blog post…
A complete guide to CO2 laser resurfacing — how the 10,600 nm wavelength ablates tissue through water chromophore absorption, the difference between full-field (traditional) and fractional CO2 resurfacing (Fraxel Re:pair, SmartXide DOT), Manstein 2004 fractional photothermolysis, the five healing phases with downtime timeline (5–10 days for fractional, 10–21 days for full-field), evidence for photoaging, scarring, and pigmentation, the PIH risk in darker skin types, and how CO2 compares to erbium:YAG and non-ablative lasers.
· By MedSpot Editorial · 6 min read
CO2 laser resurfacing uses a 10,600 nm carbon dioxide laser to ablate skin tissue through water chromophore absorption — removing damaged epidermal and dermal tissue and triggering collagen remodeling in the wound-healing response. It remains the gold standard for treating moderate-to-severe photoaging, acne scarring, and skin texture irregularities when downtime is acceptable. Here is a complete guide.
The CO2 laser wavelength at 10,600 nm is strongly absorbed by water — and skin tissue is approximately 70% water. This means:
Each CO2 laser pulse creates two distinct tissue zones:
Zone of ablation: The superficial tissue vaporized by the laser pulse. For fractional CO2, this is the micro-ablative column (MAC) — a column of vaporized tissue typically 100–200 μm in diameter and 100–1000 μm deep depending on settings.
Zone of coagulation: Surrounding tissue heated but not vaporized — protein denaturation and collagen shrinkage occur. This thermal injury triggers the wound-healing response and collagen remodeling.
The original CO2 resurfacing technique ablates 100% of the treatment area — every square millimeter of epidermis is vaporized. The entire treatment surface must heal from scratch.
Advantages: Maximum effect per treatment — full-field CO2 is the most powerful resurfacing modality available; significant improvement in severe photoaging and scarring in a single treatment.
Disadvantages:
Current use: Full-field CO2 is still used for severely photodamaged skin, extensive acne scarring, or when maximum effect is required — but fractional CO2 has replaced it for most clinical indications due to the dramatically improved safety profile.
Fractional photothermolysis (Manstein et al., 2004, Seminars in Cutaneous Medicine and Surgery): The foundational concept: treating only a fraction of the skin surface with each pass — discrete microscopic columns of treated tissue surrounded by untreated, healthy tissue bridges. The healthy bridges provide:
Fraxel Re:pair (Solta Medical/Bausch Health): The most widely studied fractional ablative CO2 platform. The 10,600 nm fractional beam creates MACs (micro-ablative columns) at variable density (5–70% treatment density) and depth (100–1600 μm).
Treatment density: The percentage of skin surface treated per session. Lower density (10–25%): more conservative, less downtime, multiple sessions needed. Higher density (40–70%): more aggressive single treatment, longer healing but maximum effect per session.
Sun-damaged skin accumulates:
Fractional CO2 ablates the damaged superficial layers and triggers new collagen synthesis in the dermis — replacing solar elastosis with organized, functional collagen:
Evidence: Walgrave et al. (2012, Lasers in Surgery and Medicine) — significant improvement in rhytid depth, skin texture, and overall photoaging scores after single fractional CO2 treatment (Fraxel Re:pair) in 27 subjects; improvement maintained at 6-month follow-up.
CO2 resurfacing is among the most effective treatments for atrophic acne scarring (boxcar and rolling scars). The ablative columns destroy fibrotic scar tissue; the collagen remodeling response fills the depressed scar base:
CO2 ablation removes the pigmented epidermis in treated columns — effective for:
Days 0–2 (acute): Immediately post-treatment, the skin appears red, swollen, and the ablative columns produce a bronzed or gridded texture. Significant edema, especially around the eyes. Pain managed with oral analgesics or prescribed pain management.
Days 2–4 (exudate): Crusting over ablative columns; serosanguinous discharge. Soaking and petroleum ointment application is critical — keeping the crust moist accelerates reepithelialization and reduces scar risk. Do not pick crusts.
Days 4–7 (reepithelialization): New epidermis migrates from untreated bridges to resurface ablative columns. By day 5–7 for fractional (low–medium density), the surface is re-epithelialized. Erythema transitions from bright red to pink.
Weeks 1–4 (erythema): Persistent pink-to-red erythema is normal. This is the inflammatory phase — new collagen is forming. Erythema duration correlates with treatment density: conservative fractional = 1–2 weeks; aggressive fractional = 2–4 weeks; full-field = 3–6 months.
Months 1–6 (remodeling): Progressive improvement in skin quality, texture, and pigmentation as new collagen matures. Full results visible at 3–6 months.
Typical social downtime:
CO2 resurfacing — both full-field and fractional — carries significant PIH risk in Fitzpatrick types III–VI. The inflammatory healing cascade following ablation triggers a melanocyte response; in skin with more reactive melanocytes, this produces patchy or diffuse darkening.
Risk management:
| Modality | Wavelength | Mechanism | Downtime | Coagulation | PIH Risk | Best For |
|---|---|---|---|---|---|---|
| CO2 (fractional) | 10,600 nm | Ablation + coagulation | 5–14 days | Significant | Moderate | Photoaging, deep scars |
| Erbium:YAG (fractional) | 2,940 nm | Ablation, minimal coagulation | 3–7 days | Minimal | Lower | Pigmentation, mild scars, darker skin |
| Fraxel Dual (non-ablative) | 1927 nm / 1550 nm | Coagulation, no ablation | 3–5 days | Yes (non-ablative) | Low–moderate | Pigmentation, mild texture |
| IPL | Broad-spectrum | Pigment + vascular | 3–7 days | No | Low | Diffuse photoaging, redness |
| Microneedling RF | RF via needles | Collagen induction | 2–4 days | Focal | Very low | Scars, laxity, all skin types |
Pre-treatment:
Post-treatment:
Looking for a CO2 laser resurfacing or skin resurfacing provider? Browse med spa providers on MedSpot →